???pagination.result.count???
Differing effects of N-methyl-D-aspartate receptor subtype selective antagonists on dyskinesias in levodopa-treated 1-methyl-4-phenyl-tetrahydropyridine monkeys. , Blanchet PJ, Konitsiotis S, Whittemore ER, Zhou ZL, Woodward RM, Chase TN., J Pharmacol Exp Ther. September 1, 1999; 290 (3): 1034-40.
Stimulatory and inhibitory properties of aminoglycoside antibiotics at N-methyl-D-aspartate receptors. , Masuko T, Kuno T, Kashiwagi K , Kusama T, Williams K, Igarashi K., J Pharmacol Exp Ther. September 1, 1999; 290 (3): 1026-33.
Structure-activity relationship of N-(phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists. , Tamiz AP, Cai SX, Zhou ZL, Yuen PW, Schelkun RM, Whittemore ER, Weber E, Woodward RM, Keana JF., J Med Chem. August 26, 1999; 42 (17): 3412-20.
NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A. , Goebel DJ, Poosch MS., Brain Res Mol Brain Res. June 8, 1999; 69 (2): 164-70.
A regulatory domain ( R1- R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein. , Masuko T, Kashiwagi K , Kuno T, Nguyen ND, Pahk AJ, Fukuchi J, Igarashi K, Williams K., Mol Pharmacol. June 1, 1999; 55 (6): 957-69.
Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action. , Kleckner NW, Glazewski JC, Chen CC , Moscrip TD., J Pharmacol Exp Ther. May 1, 1999; 289 (2): 886-94.
Protein kinase C modulation of recombinant NMDA receptor currents: roles for the C-terminal C1 exon and calcium ions. , Logan SM, Rivera FE, Leonard JP., J Neurosci. February 1, 1999; 19 (3): 974-86.
Structure-activity relationships for a series of bis(phenylalkyl)amines: potent subtype-selective inhibitors of N-methyl-D-aspartate receptors. , Tamiz AP, Whittemore ER, Zhou ZL, Huang JC, Drewe JA, Chen JC , Cai SX, Weber E, Woodward RM, Keana JF., J Med Chem. August 27, 1998; 41 (18): 3499-506.
Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. , Traynelis SF, Burgess MF, Zheng F, Lyuboslavsky P, Powers JL., J Neurosci. August 15, 1998; 18 (16): 6163-75.
Differentiation of glycine antagonist sites of N-methyl-D-aspartate receptor subtypes. Preferential interaction of CGP 61594 with NR1/2B receptors. , Honer M, Benke D, Laube B, Kuhse J, Heckendorn R, Allgeier H, Angst C, Monyer H, Seeburg PH, Betz H, Mohler H., J Biol Chem. May 1, 1998; 273 (18): 11158-63.
Evidence for a tetrameric structure of recombinant NMDA receptors. , Laube B, Kuhse J, Betz H., J Neurosci. April 15, 1998; 18 (8): 2954-61.
Antagonist properties of a phosphono isoxazole amino acid at glutamate R1-4 (R,S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor subtypes. , Wahl P, Anker C, Traynelis SF, Egebjerg J, Rasmussen JS, Krogsgaard-Larsen P, Madsen U., Mol Pharmacol. March 1, 1998; 53 (3): 590-6.
State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist. , Kew JN, Trube G, Kemp JA., Br J Pharmacol. February 1, 1998; 123 (3): 463-72.
Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. , Fischer G, Mutel V, Trube G, Malherbe P, Kew JN, Mohacsi E, Heitz MP, Kemp JA., J Pharmacol Exp Ther. December 1, 1997; 283 (3): 1285-92.
Benzyl-polyamines: novel, potent N-methyl-D-aspartate receptor antagonists. , Igarashi K, Shirahata A, Pahk AJ, Kashiwagi K , Williams K., J Pharmacol Exp Ther. November 1, 1997; 283 (2): 533-40.
Stoichiometry of recombinant N-methyl-D-aspartate receptor channels inferred from single-channel current patterns. , Premkumar LS, Auerbach A., J Gen Physiol. November 1, 1997; 110 (5): 485-502.
High-affinity zinc inhibition of NMDA NR1- NR2A receptors. , Paoletti P, Ascher P, Neyton J., J Neurosci. August 1, 1997; 17 (15): 5711-25.
Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition. , Whittemore ER, Ilyin VI, Woodward RM., J Pharmacol Exp Ther. July 1, 1997; 282 (1): 326-38.
Influence of extracellular pH on inhibition by ifenprodil at N-methyl-D-aspartate receptors in Xenopus oocytes. , Pahk AJ, Williams K., Neurosci Lett. March 28, 1997; 225 (1): 29-32.
Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/ NR2A and NR1A/ NR2B receptors expressed in Xenopus oocytes. , Avenet P, Léonardon J, Besnard F, Graham D, Depoortere H, Scatton B., Neurosci Lett. February 21, 1997; 223 (2): 133-6.
Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/ NR2D heteromers expressed in Xenopus oocytes. , Buller AL, Monaghan DT., Eur J Pharmacol. February 5, 1997; 320 (1): 87-94.
Subconductance states of a mutant NMDA receptor channel kinetics, calcium, and voltage dependence. , Premkumar LS, Qin F, Auerbach A., J Gen Physiol. February 1, 1997; 109 (2): 181-9.
NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology. , Monaghan DT, Larsen H., J Pharmacol Exp Ther. February 1, 1997; 280 (2): 614-20.
Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. , Ilyin VI, Whittemore ER, Guastella J, Weber E, Woodward RM., Mol Pharmacol. December 1, 1996; 50 (6): 1541-50.
Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors. , Zhong J, Gribkoff VK, Molinoff PB., Mol Pharmacol. September 1, 1996; 50 (3): 631-8.
Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors. , Hess SD, Daggett LP, Crona J, Deal C, Lu CC, Urrutia A, Chavez-Noriega L, Ellis SB, Johnson EC, Veliçelebi G., J Pharmacol Exp Ther. August 1, 1996; 278 (2): 808-16.
Alternative splicing of the NMDAR1 subunit affects modulation by calcium. , Koltchine VV, Anantharam V, Bayley H, Treistman SN., Brain Res Mol Brain Res. July 1, 1996; 39 (1-2): 99-108.
An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons. , Kashiwagi K , Fukuchi J, Chao J, Igarashi K, Williams K., Mol Pharmacol. June 1, 1996; 49 (6): 1131-41.
Multiple structural elements determine subunit specificity of Mg2+ block in NMDA receptor channels. , Kuner T, Schoepfer R., J Neurosci. June 1, 1996; 16 (11): 3549-58.
The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits. , de Carvalho LP, Bochet P, Rossier J., Neurochem Int. April 1, 1996; 28 (4): 445-52.
Antagonist properties of the stereoisomers of ifenprodil at NR1A/ NR2A and NR1A/ NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes. , Avenet P, Léonardon J, Besnard F, Graham D, Frost J, Depoortere H, Langer SZ, Scatton B., Eur J Pharmacol. January 25, 1996; 296 (2): 209-13.
An acidic amino acid in the N-methyl-D-aspartate receptor that is important for spermine stimulation. , Williams K, Kashiwagi K , Fukuchi J, Igarashi K., Mol Pharmacol. December 1, 1995; 48 (6): 1087-98.
Glycine-independent and subunit-specific potentiation of NMDA responses by extracellular Mg2+. , Paoletti P, Neyton J, Ascher P., Neuron. November 1, 1995; 15 (5): 1109-20.
Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes. , Buller AL, Larson HC, Morrisett RA, Monaghan DT., Mol Pharmacol. October 1, 1995; 48 (4): 717-23.
Developmental and regional expression pattern of a novel NMDA receptor-like subunit ( NMDAR-L) in the rodent brain. , Sucher NJ, Akbarian S, Chi CL, Leclerc CL , Awobuluyi M, Deitcher DL, Wu MK, Yuan JP, Jones EG, Lipton SA., J Neurosci. October 1, 1995; 15 (10): 6509-20.
Ethanol inhibition of recombinant heteromeric NMDA channels in the presence and absence of modulators. , Chu B, Anantharam V, Treistman SN., J Neurochem. July 1, 1995; 65 (1): 140-8.
Block of the N-methyl-D-aspartate receptor by phencyclidine-like drugs is influenced by alternative splicing. , Rodríguez-Paz JM, Anantharam V, Treistman SN., Neurosci Lett. May 12, 1995; 190 (3): 147-50.
Antagonist properties of polyamines and bis(ethyl)polyamines at N-methyl-D-aspartate receptors. , Igarashi K, Williams K., J Pharmacol Exp Ther. March 1, 1995; 272 (3): 1101-9.
Pharmacological properties of recombinant N-methyl-D-aspartate (NMDA) receptors containing the epsilon 4 ( NR2D) subunit. , Williams K., Neurosci Lett. January 30, 1995; 184 (3): 181-4.
Spermine potentiation of recombinant N-methyl-D-aspartate receptors is affected by subunit composition. , Zhang L, Zheng X, Paupard MC, Wang AP , Santchi L, Friedman LK, Zukin RS, Bennett MV., Proc Natl Acad Sci U S A. November 8, 1994; 91 (23): 10883-7.
Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. , Sullivan JM, Traynelis SF, Chen HS , Escobar W, Heinemann SF, Lipton SA., Neuron. October 1, 1994; 13 (4): 929-36.
Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine. , Williams K., Mol Pharmacol. September 1, 1994; 46 (3): 531-41.
The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition. , Buller AL, Larson HC, Schneider BE, Beaton JA, Morrisett RA, Monaghan DT., J Neurosci. September 1, 1994; 14 (9): 5471-84.
Mechanisms influencing stimulatory effects of spermine at recombinant N-methyl-D-aspartate receptors. , Williams K., Mol Pharmacol. July 1, 1994; 46 (1): 161-8.
Cloning, functional coexpression, and pharmacological characterisation of human cDNAs encoding NMDA receptor NR1 and NR2A subunits. , Le Bourdellès B, Wafford KA, Kemp JA, Marshall G, Bain C, Wilcox AS, Sikela JM, Whiting PJ., J Neurochem. June 1, 1994; 62 (6): 2091-8.
Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. , Williams K, Zappia AM, Pritchett DB, Shen YM, Molinoff PB., Mol Pharmacol. May 1, 1994; 45 (5): 803-9.
Ethanol inhibits glutamate-induced currents in heteromeric NMDA receptor subtypes. , Kuner T, Schoepfer R, Korpi ER., Neuroreport. December 13, 1993; 5 (3): 297-300.
Glycine-glutamate interactions at the NMDA receptor: role of cysteine residues. , Laube B, Kuryatov A, Kuhse J, Betz H., FEBS Lett. December 13, 1993; 335 (3): 331-4.
Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. , Williams K., Mol Pharmacol. October 1, 1993; 44 (4): 851-9.
Subunit-specific block of cloned NMDA receptors by argiotoxin636. , Raditsch M, Ruppersberg JP, Kuner T, Günther W, Schoepfer R, Seeburg PH, Jahn W, Witzemann V., FEBS Lett. June 7, 1993; 324 (1): 63-6.